Common germline polymorphisms associated with breast cancer-specific survival.

Autor: Pirie A; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. ap736@medschl.cam.ac.uk., Guo Q; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. qg209@medschl.cam.ac.uk., Kraft P; Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. pkraft@hsph.harvard.edu.; Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. pkraft@hsph.harvard.edu., Canisius S; Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. s.canisius@nki.nl., Eccles DM; Faculty of Medicine, University of Southampton, Highfield Campus, Southampton, SO17 1BJ, UK. d.m.eccles@soton.ac.uk., Rahman N; Division of Genetics and Epidemiology, Institute of Cancer Research, 15 Cotswold Road, Sutton, SM2 5NG, Surrey, UK. Nazneen.Rahman@icr.ac.uk., Nevanlinna H; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, FIN-00029 HUS, Helsinki, Finland. Heli.Nevanlinna@hus.fi., Chen C; Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. cjchen@hsph.harvard.edu., Khan S; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, FIN-00029 HUS, Helsinki, Finland. sofia.khan@helsinki.fi., Tyrer J; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. jpt34@medschl.cam.ac.uk., Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. mkh39@medschl.cam.ac.uk., Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. qw232@medschl.cam.ac.uk., Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. jgd29@cam.ac.uk., Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. km533@medschl.cam.ac.uk., Lush M; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. mjl81@medschl.cam.ac.uk., Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. amd24@medschl.cam.ac.uk., Shah M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. ms483@medschl.cam.ac.uk., Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. kamila.czene@ki.se., Darabi H; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. hatef.darabi@ki.se., Eriksson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. mikael.eriksson@ki.se., Lambrechts D; Vesalius Research Center (VRC), Vib, Herestraat 49, 3000, Leuven, Belgium. diether.lambrechts@med.kuleuven.be.; Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Herestraat 49, 3000, Leuven, Belgium. diether.lambrechts@med.kuleuven.be., Weltens C; Oncology Department, University Hospital Gasthuisberg, Herestraat 49, 3000, Leuven, Belgium. caroline.weltens@uzleuven.be., Leunen K; Oncology Department, University Hospital Gasthuisberg, Herestraat 49, 3000, Leuven, Belgium. karin.leunen@uzleuven.be., van Ongeval C; Oncology Department, University Hospital Gasthuisberg, Herestraat 49, 3000, Leuven, Belgium. Chantal.VanOngeval@uzleuven.be., Nordestgaard BG; Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. boerge.nordestgaard@regionh.dk.; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. boerge.nordestgaard@regionh.dk.; Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2220, Copenhagen, Denmark. boerge.nordestgaard@regionh.dk., Nielsen SF; Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. sune.fallgaard.nielsen@regionh.dk.; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. sune.fallgaard.nielsen@regionh.dk., Flyger H; Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. henrik.flyger@regionh.dk., Rudolph A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. a.rudolph@dkfz.de., Seibold P; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. p.seibold@dkfz.de., Flesch-Janys D; Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. flesch@uke.uni-hamburg.de., Blomqvist C; Department of Oncology, Helsinki University Central Hospital, Sairaalatie 8, 08 200 LOHJA, Helsinki, Finland. carl.blomqvist@helsinki.fi., Aittomäki K; Department of Clinical Genetics, Helsinki University Central Hospital, Sairaalatie 8, 08 200 LOHJA, Helsinki, Finland. kristiina.aittomaki@hus.fi., Fagerholm R; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, FIN-00029 HUS, Helsinki, Finland. Heli.Nevanlinna@hus.fi.; Department of Oncology, Helsinki University Central Hospital, Sairaalatie 8, 08 200 LOHJA, Helsinki, Finland. Heli.Nevanlinna@hus.fi.; Department of Clinical Genetics, Helsinki University Central Hospital, Sairaalatie 8, 08 200 LOHJA, Helsinki, Finland. Heli.Nevanlinna@hus.fi., Muranen TA; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, FIN-00029 HUS, Helsinki, Finland. taru.a.muranen@helsinki.fi., Olsen JE; Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. olsonj@mayo.edu., Hallberg E; Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. Hallberg.emily@mayo.edu., Vachon C; Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. vachon.celine@mayo.edu., Knight JA; Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G 1X5, Canada. knight@lunenfeld.ca.; Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, 155 College Street, Toronto, ON, M5T 3M7, Canada. knight@lunenfeld.ca., Glendon G; Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G 1X5, Canada. gglendon@uhnresearch.ca., Mulligan AM; Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada. AnnaMarie.Mulligan@uhn.ca.; Laboratory Medicine Program, University Health Network, 200 Elizabeth Street, Toronto, ON, M5G 2C4, Canada. AnnaMarie.Mulligan@uhn.ca., Broeks A; Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. a.broeks@nki.nl., Cornelissen S; Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. s.cornelissen@nki.nl., Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 Zonal Avenue, Los Angeles, CA, 90033, USA. Christopher.Haiman@med.usc.edu., Henderson BE; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 Zonal Avenue, Los Angeles, CA, 90033, USA. Behender@usc.edu., Schumacher F; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 Zonal Avenue, Los Angeles, CA, 90033, USA. fschumac@usc.edu., Le Marchand L; Cancer Research Center of Hawaii, University of Hawaii, 701 Ilalo Street, Honolulu, HI, 96813, USA. loic@crch.hawaii.edu., Hopper JL; Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. j.hopper@unimelb.edu.au., Tsimiklis H; Department of Pathology, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. htsi@unimelb.edu.au., Apicella C; Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. capic@unimelb.edu.au., Southey MC; Department of Pathology, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. msouthey@unimelb.edu.au., Cross SS; Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, 385a Glossop Road, Sheffield, S10 2HQ, UK. s.s.cross@sheffield.ac.uk., Reed MW; CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK. m.w.reed@sheffield.ac.uk., Giles GG; Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. Graham.Giles@cancervic.org.au.; Cancer Epidemiology Centre, The Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia. Graham.Giles@cancervic.org.au., Milne RL; Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. Roger.Milne@cancervic.org.au.; Cancer Epidemiology Centre, The Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia. Roger.Milne@cancervic.org.au., McLean C; Anatomical Pathology, The Alfred Hospital, Commercial Road, Melbourne, VIC, 3007, Australia. C.McLean@alfred.org.au., Winqvist R; Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Genetics and Biocenter Oulu, University of Oulu, Oulu University Hospital, Kajaanintie 50, FI-90220, Oulu, Finland. robert.winqvist@oulu.fi., Pylkäs K; Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Genetics and Biocenter Oulu, University of Oulu, Oulu University Hospital, Kajaanintie 50, FI-90220, Oulu, Finland. katri.pylkas@oulu.fi., Jukkola-Vuorinen A; Department of Oncology, Oulu University Hospital, University of Oulu, Kajaanintie 50, FI-90220, Oulu, Finland. arja.jukkola-vuorinen@ppshp.fi., Grip M; Department of Surgery, Oulu University Hospital, University of Oulu, Kajaanintie 50, FI-90220, Oulu, Finland. mervi.grip@ppshp.fi., Hooning MJ; Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. m.hooning@erasmusmc.nl., Hollestelle A; Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. a.hollestelle@erasmusmc.nl., Martens JW; Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. j.martens@erasmusmc.nl., van den Ouweland AM; Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. a.vandenouweland@erasmusmc.nl., Marme F; Department of Obstetrics and Gynecology, University of Heidelberg, Voßstrasse 9, 69115, Heidelberg, Germany. frederikmarme@gmail.com.; National Center for Tumor Diseases, University of Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. frederikmarme@gmail.com., Schneeweiss A; Department of Obstetrics and Gynecology, University of Heidelberg, Voßstrasse 9, 69115, Heidelberg, Germany. Andreas.Schneeweiss@med.uni-heidelberg.de.; National Center for Tumor Diseases, University of Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. Andreas.Schneeweiss@med.uni-heidelberg.de., Yang R; Department of Obstetrics and Gynecology, University of Heidelberg, Voßstrasse 9, 69115, Heidelberg, Germany. R.Yang@dkfz.de., Burwinkel B; Department of Obstetrics and Gynecology, University of Heidelberg, Voßstrasse 9, 69115, Heidelberg, Germany. Barbara.Burwinkel@med.uni-heidelberg.de.; Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. Barbara.Burwinkel@med.uni-heidelberg.de., Figueroa J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD, 20892, USA. figueroaj@mail.nih.gov., Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD, 20892, USA. chanocks@mail.nih.gov.; Core Genotyping Facility, Frederick National Laboratory for Cancer Research, 8717 Grovemont Circle, Gaithersburg, MD, 20877, USA. chanocks@mail.nih.gov., Lissowska J; Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Roentena 5, 02-781, Warsaw, Poland. lissowsj@coi.waw.pl., Sawyer EJ; Division of Cancer Studies, NIHR Comprehensive Biomedical Research Centre, Guy's and St. Thomas' NHS Foundation Trust in Partnership with King's College London, Guy's Campus, SE1 1UL, London, UK. chanocks@mail.nih.gov., Tomlinson I; Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK. iant@well.ox.ac.uk., Kerin MJ; Clinical Science Institute, University Hospital Galway, Newcastle Road, Galway, Ireland. michael.kerin@nuigalway.ie., Miller N; Clinical Science Institute, University Hospital Galway, Newcastle Road, Galway, Ireland. nicola.miller@nuigalway.ie., Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120, Heidelberg, Germany. h.brenner@dkfz.de.; German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. h.brenner@dkfz.de., Butterbach K; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120, Heidelberg, Germany. k.butterbach@dkfz.de., Holleczek B; Saarland Cancer Registry, Präsident Baltz Strasse 5, 66119, Saarbrücken, Germany. b.holleczek@gbe-ekr.saarland.de., Kataja V; School of Medicine, Institute of Clinical Medicine, Oncology and Cancer Center, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland. vesa.kataja@kuh.fi., Kosma VM; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine and Cancer Center of Eastern Finland, University of Eastern Finland, Yliopistonranta 1C, 70210, Kuopio, Finland. veli-matti.kosma@uef.fi.; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland. veli-matti.kosma@uef.fi., Hartikainen JM; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine and Cancer Center of Eastern Finland, University of Eastern Finland, Yliopistonranta 1C, 70210, Kuopio, Finland. jaana.hartikainen@uef.fi.; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland. jaana.hartikainen@uef.fi., Li J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. jingmei@gmail.com., Brand JS; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. judith.brand@ki.se., Humphreys K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. Keith.Humphreys@ki.se., Devilee P; Department of Human Genetics and Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. p.devilee@lumc.nl., Tollenaar RA; Department of Surgical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. r.a.e.m.tollenaar@lumc.nl., Seynaeve C; Department of Medical Oncology, Family Cancer Clinic, Erasmus McCancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. c.seynaeve@erasmusmc.nl., Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori (INT), Via Adamello 16, Milan, 20139, Italy. paolo.radice@istitutotumori.mi.it., Peterlongo P; IFOM, Fondazione Istituto FIRC Di Oncologia Molecolare, Via Adamello 16, 20139, Milan, Italy. paolo.peterlongo@ifom.eu., Manoukian S; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori (INT), Via Adamello 16, Milan, 20139, Italy. siranoush.manoukian@istitutotumori.mi.it., Ficarazzi F; IFOM, Fondazione Istituto FIRC Di Oncologia Molecolare, Via Adamello 16, 20139, Milan, Italy. filomena.ficarazzi@ifom.eu.; Cogentech Cancer Genetic Test Laboratory, Via Adamello 16, 20139, Milan, Italy. filomena.ficarazzi@ifom.eu., Beckmann MW; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Emn, Universitaetsstrasse 21-23, 91054, Erlangen, Germany. fk-direktion@uk-erlangen.de., Hein A; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Emn, Universitaetsstrasse 21-23, 91054, Erlangen, Germany. alexander.hein@uk-erlangen.de., Ekici AB; Institute of Human Genetics; University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Emn, Universitaetsstrasse 21-23, 91054, Erlangen, Germany. arif.ekici@uk-erlangen.de., Balleine R; Western Sydney and Nepean Blue Mountains Local Health Districts, Westmead Millennium Institute for Medical Research, University of Sydney, 176 Hawkesbury Road, Sydney, NSW 2145, Australia. rosemary.balleine@sydney.edu.au., Phillips KA; Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC, 3010, Australia. Kelly.Phillips@petermac.org.; Peter Maccallum Cancer Center, 2 St Andrews Place, Melbourne, VIC, 3002, Australia. Kelly.Phillips@petermac.org.; Sir Peter Maccallum Department of Oncology, University of Melbourne, 2 St Andrews Place, Melbourne, VIC, 3002, Australia. Kelly.Phillips@petermac.org., Benitez J; Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Calle de Melchor Fernández, Almagro, 3, 28029, Madrid, Spain. jbenitez@cnio.es.; Centro de Investigación En Red De Enfermedades Raras (CIBERER), Calle de Álvaro de Bazán, 10 Bajo, 46010, Valencia, Spain. jbenitez@cnio.es., Zamora MP; Servicio de Oncología Médica, Hospital Universitario La Paz, Paseo de la Castellana, 261, 28046, Madrid, Spain. zamorapilar@gmail.com., Perez JI; Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Avenida Doctores Fernández Vega, 107, 33012, Oviedo, Spain. jiarias@msn.com., Menéndez P; Servicio de Anatomía Patológica, Hospital Monte Naranco, Avenida Doctores Fernández Vega, 107, 33012, Oviedo, Spain. tiva@hca.es., Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, ul. Rybacka 1, Szczecin, Poland. aniaj@sci.pam.szczecin.pl., Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, ul. Rybacka 1, Szczecin, Poland. lubinski@sci.pam.szczecin.pl., Gronwald J; Department of Genetics and Pathology, Pomeranian Medical University, ul. Rybacka 1, Szczecin, Poland. jgron@sci.pum.edu.pl., Durda K; Department of Genetics and Pathology, Pomeranian Medical University, ul. Rybacka 1, Szczecin, Poland. k.durda@onet.pl., Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. u.hamann@dkfz-heidelberg.de., Kabisch M; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. m.kabisch@dkfz-heidelberg.de., Ulmer HU; Frauenklinik der Stadtklinik Baden-Baden, Balger Strasse 50, 76532, Baden-Baden, Germany. hu.ulmer@klinikum-mittelbaden.de., Rüdiger T; Institute of Pathology, Städtisches Klinikum Karlsruhe, Moltkestrasse 90, 76133, Karlsruhe, Germany. Thomas.Ruediger@klinikum-karlsruhe.de., Margolin S; Department of Oncology - Pathology, Karolinska Institutet, Tomtebodavägen 23b, Stockholm, 171 65, Sweden. Sara.Margolin@karolinska.se., Kristensen V; Faculty of Medicine (Faculty Division Ahus), University of Oslo (UiO), Problemveien 7, Oslo, 0313, Norway. Vessela.N.Kristensen@rr-research.no.; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Montebello, 0379, Oslo, Norway. Vessela.N.Kristensen@rr-research.no., Nord S; Faculty of Medicine (Faculty Division Ahus), University of Oslo (UiO), Problemveien 7, Oslo, 0313, Norway. silje.nordgard@gmail.com.; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Montebello, 0379, Oslo, Norway. silje.nordgard@gmail.com., Evans DG; Genomic Medicine, Manchester Academic Health Science Centre, University of Manchester, Central Manchester Foundation Trust, St. Mary's Hospital, Oxford Road, Manchester, M13 9WL, UK. Gareth.Evans@cmft.nhs.uk., Abraham J; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. ja344@medschl.cam.ac.uk.; Cambridge Experimental Cancer Medicine Centre, Robinson Way, Cambridge, CB2 0RE, UK. ja344@medschl.cam.ac.uk.; Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Hills Road, Cambridge, CB2 0QQ, UK. ja344@medschl.cam.ac.uk., Earl H; Cambridge Experimental Cancer Medicine Centre, Robinson Way, Cambridge, CB2 0RE, UK. hme22@cam.ac.uk.; Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Hills Road, Cambridge, CB2 0QQ, UK. hme22@cam.ac.uk., Poole CJ; Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Campus, Coventry, CV4 7AL, UK. christopher.poole@warwick.ac.uk., Hiller L; Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Campus, Coventry, CV4 7AL, UK. l.hiller@warwick.ac.uk., Dunn JA; Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Campus, Coventry, CV4 7AL, UK. j.a.dunn@warwick.ac.uk., Bowden S; Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, the University of Birmingham, Vincent Drive, Edgbaston, Birmingham, B15 2TT, UK. s.j.bowden@bham.ac.uk., Yang R; Early Detection Research Group, Division of Cancer Prevention National Cancer Institute, 9609 Medical Center Drive, Bethesda, MD, 20892, USA. royang@mail.nih.gov., Campa D; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. d.campa@dkfz-heidelberg.de.; Department of Biology, University of Pisa, Lungarno Pacinotti 43, 56126, Pisa, Italy. d.campa@dkfz-heidelberg.de., Diver WR; Epidemiology Research Program, American Cancer Society, 250 Williams Street, Atlanta, GA, 30303, USA. Ryan.diver@cancer.org., Gapstur SM; Epidemiology Research Program, American Cancer Society, 250 Williams Street, Atlanta, GA, 30303, USA. Susan.gapstur@cancer.org., Gaudet MM; Epidemiology Research Program, American Cancer Society, 250 Williams Street, Atlanta, GA, 30303, USA. Mia.gaudet@cancer.org., Hankinson S; Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. shankinson@schoolph.umass.edu.; Division of Biostatistics and Epidemiology, University of Massachusetts-Amherst School of Public Health and Health Sciences, 715 N Pleasant Street, Amherst, MA, 01002, USA. shankinson@schoolph.umass.edu.; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA. shankinson@schoolph.umass.edu., Hoover RN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD, 20892, USA. hooverr@exchange.nih.gov., Hüsing A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. a.huesing@dkfz.de., Kaaks R; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. r.kaaks@dkfz.de., Machiela MJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD, 20892, USA. Mitchell.machiela@nih.gov., Willett W; Department of Nutrition, Harvard School of Public Health, 655 Huntington Avenue, Boston, MA, 02115, USA. wwillett@hsph.harvard.edu., Barrdahl M; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. m.barrdahl@Dkfz-Heidelberg.de., Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. f.canzian@dkfz-heidelberg.de., Chin SF; Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, CB2 0RE, UK. Suet-Feung.Chin@cruk.cam.ac.uk., Caldas C; Cambridge Experimental Cancer Medicine Centre, Robinson Way, Cambridge, CB2 0RE, UK. carlos.caldas@cruk.cam.ac.uk.; Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Hills Road, Cambridge, CB2 0QQ, UK. carlos.caldas@cruk.cam.ac.uk.; Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, CB2 0RE, UK. carlos.caldas@cruk.cam.ac.uk., Hunter DJ; Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. dhunter@hsph.harvard.edu.; Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. dhunter@hsph.harvard.edu., Lindstrom S; Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. slindstr@hsph.harvard.edu.; Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA. slindstr@hsph.harvard.edu., Garcia-Closas M; Division of Genetics and Epidemiology, Institute of Cancer Research, 15 Cotswold Road, Sutton, SM2 5NG, Surrey, UK. Montse.GarciaClosas@icr.ac.uk.; Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP, UK. Montse.GarciaClosas@icr.ac.uk., Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. couch.fergus@mayo.edu., Chenevix-Trench G; Department of Genetics, Qimr Berghofer Medical Research Institute, 300 Herston Road, Brisbane, QLD 4006, Australia. Georgia.Trench@qimrberghofer.edu.au., Mannermaa A; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine and Cancer Center of Eastern Finland, University of Eastern Finland, Yliopistonranta 1C, 70210, Kuopio, Finland. arto.mannermaa@uef.fi.; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland. arto.mannermaa@uef.fi., Andrulis IL; Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G 1X5, Canada. andrulis@lunenfeld.ca.; Department of Molecular Genetics, University of Toronto, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada. andrulis@lunenfeld.ca., Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, Stockholm, 17177, Sweden. Per.Hall@ki.se., Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. j.chang-claude@dkfz-heidelberg.de., Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. dfe20@medschl.cam.ac.uk.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. dfe20@medschl.cam.ac.uk., Bojesen SE; Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. stig.egil.bojesen@regionh.dk.; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Copenhagen, Denmark. stig.egil.bojesen@regionh.dk.; Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2220, Copenhagen, Denmark. stig.egil.bojesen@regionh.dk., Cox A; CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK. a.cox@shef.ac.uk., Fasching PA; Institute of Human Genetics; University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Emn, Universitaetsstrasse 21-23, 91054, Erlangen, Germany. peter.fasching@uk-erlangen.de.; David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, University of California at Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA, 90095, USA. peter.fasching@uk-erlangen.de., Pharoah PD; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. pp10001@medschl.cam.ac.uk.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Wort's Causeway, Cambridge, CB1 8RN, UK. pp10001@medschl.cam.ac.uk., Schmidt MK; Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. mk.schmidt@nki.nl.

Publikováno v: Breast cancer research : BCR [Breast Cancer Res] 2015 Apr 22; Vol. 17, pp. 58. Date of Electronic Publication: 2015 Apr 22.